Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.12
WLP's Cash to Debt is ranked higher than
55% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.56 vs. WLP: 0.12 )
WLP' s 10-Year Cash to Debt Range
Min: 0.09   Max: 0.59
Current: 0.12

0.09
0.59
Equity to Asset 0.39
WLP's Equity to Asset is ranked higher than
76% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.38 vs. WLP: 0.39 )
WLP' s 10-Year Equity to Asset Range
Min: 0.33   Max: 0.51
Current: 0.39

0.33
0.51
Interest Coverage 6.37
WLP's Interest Coverage is ranked higher than
64% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.28 vs. WLP: 6.37 )
WLP' s 10-Year Interest Coverage Range
Min: 6.37   Max: 9999.99
Current: 6.37

6.37
9999.99
F-Score: 5
Z-Score: 2.11
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 5.41
WLP's Operating margin (%) is ranked higher than
82% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.65 vs. WLP: 5.41 )
WLP' s 10-Year Operating margin (%) Range
Min: 5.1   Max: 11.38
Current: 5.41

5.1
11.38
Net-margin (%) 3.51
WLP's Net-margin (%) is ranked higher than
76% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.98 vs. WLP: 3.51 )
WLP' s 10-Year Net-margin (%) Range
Min: 0.36   Max: 7.3
Current: 3.51

0.36
7.3
ROE (%) 10.05
WLP's ROE (%) is ranked higher than
67% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.83 vs. WLP: 10.05 )
WLP' s 10-Year ROE (%) Range
Min: 2.7   Max: 19.09
Current: 10.05

2.7
19.09
ROA (%) 4.18
WLP's ROA (%) is ranked higher than
70% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.33 vs. WLP: 4.18 )
WLP' s 10-Year ROA (%) Range
Min: 0.93   Max: 9.1
Current: 4.18

0.93
9.1
ROC (Joel Greenblatt) (%) 213.17
WLP's ROC (Joel Greenblatt) (%) is ranked higher than
84% of the 32 Companies
in the Global Health Care Plans industry.

( Industry Median: 134.04 vs. WLP: 213.17 )
WLP' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 151.7   Max: 673.24
Current: 213.17

151.7
673.24
Revenue Growth (%) 18.30
WLP's Revenue Growth (%) is ranked higher than
86% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.00 vs. WLP: 18.30 )
WLP' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 18.3
Current: 18.3

0
18.3
EBITDA Growth (%) 10.90
WLP's EBITDA Growth (%) is ranked higher than
84% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.80 vs. WLP: 10.90 )
WLP' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 28
Current: 10.9

0
28
EPS Growth (%) 7.70
WLP's EPS Growth (%) is ranked higher than
76% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.00 vs. WLP: 7.70 )
WLP' s 10-Year EPS Growth (%) Range
Min: 0   Max: 27
Current: 7.7

0
27
» WLP's 10-Y Financials

Financials


Revenue & Net Income
Equity & Asset
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

WLP Guru Trades in Q3 2013

John Hussman 150,000 sh (New)
Steven Cohen 98,488 sh (+4172.8%)
Ray Dalio 59,026 sh (+63.39%)
Jeremy Grantham 676,902 sh (+61.86%)
First Pacific Advisors 2,276,400 sh (+0.15%)
Yacktman Focused Fund 1,600,000 sh (unchged)
Bernard Horn 36,600 sh (unchged)
Chris Davis 7,880 sh (unchged)
Steven Romick 2,025,000 sh (unchged)
Joel Greenblatt 2,837 sh (unchged)
Yacktman Fund 1,406,800 sh (unchged)
Dodge & Cox 3,000 sh (unchged)
Tom Gayner 78,000 sh (unchged)
Jeff Auxier 63,471 sh (unchged)
David Dreman Sold Out
Louis Moore Bacon Sold Out
James Barrow 17,365,475 sh (-0.38%)
Donald Yacktman 3,618,166 sh (-0.68%)
HOTCHKIS & WILEY 3,109,279 sh (-1.54%)
Richard Snow 821,580 sh (-3.36%)
Vanguard Health Care Fund 7,187,500 sh (-6.68%)
Jean-Marie Eveillard 5,250,235 sh (-16.29%)
Paul Tudor Jones 9,300 sh (-96.34%)
» More
Q4 2013

WLP Guru Trades in Q4 2013

Jim Simons 24,973 sh (New)
David Dreman 2,297 sh (New)
Paul Tudor Jones 190,924 sh (+1952.95%)
Chris Davis 100,341 sh (+1173.36%)
Jeremy Grantham 1,613,844 sh (+138.42%)
Tom Gayner 106,000 sh (+35.9%)
James Barrow 17,468,810 sh (+0.6%)
Jean-Marie Eveillard 5,275,335 sh (+0.48%)
First Pacific Advisors 2,280,600 sh (+0.18%)
John Hussman 150,000 sh (unchged)
Bernard Horn 36,600 sh (unchged)
Dodge & Cox 3,000 sh (unchged)
Yacktman Focused Fund 1,600,000 sh (unchged)
Jeff Auxier 63,471 sh (unchged)
Steven Romick 2,025,000 sh (unchged)
Yacktman Fund 1,406,800 sh (unchged)
Ray Dalio Sold Out
Donald Yacktman 3,607,114 sh (-0.31%)
HOTCHKIS & WILEY 3,015,146 sh (-3.03%)
Joel Greenblatt 2,722 sh (-4.05%)
Vanguard Health Care Fund 6,349,200 sh (-11.66%)
Richard Snow 597,154 sh (-27.32%)
Steven Cohen 2,433 sh (-97.53%)
» More
Q1 2014

WLP Guru Trades in Q1 2014

Mario Gabelli 8,000 sh (New)
George Soros 110,000 sh (New)
Louis Moore Bacon 4,674 sh (New)
Ray Dalio 16,026 sh (New)
Larry Robbins 4,231,950 sh (New)
Jim Simons 345,747 sh (+1284.48%)
Steven Cohen 26,248 sh (+978.83%)
Joel Greenblatt 9,127 sh (+235.3%)
Tom Gayner 134,000 sh (+26.42%)
Jeremy Grantham 1,981,566 sh (+22.79%)
HOTCHKIS & WILEY 3,296,687 sh (+9.34%)
David Dreman 2,467 sh (+7.4%)
Jean-Marie Eveillard 5,307,814 sh (+0.62%)
First Pacific Advisors 2,288,500 sh (+0.35%)
Steven Romick 2,025,000 sh (unchged)
Yacktman Fund 1,406,800 sh (unchged)
Bernard Horn 36,600 sh (unchged)
Yacktman Focused Fund 1,600,000 sh (unchged)
Dodge & Cox 3,000 sh (unchged)
John Hussman Sold Out
Jeff Auxier 63,446 sh (-0.04%)
Donald Yacktman 3,581,058 sh (-0.72%)
Chris Davis 87,047 sh (-13.25%)
James Barrow 13,212,766 sh (-24.36%)
Vanguard Health Care Fund 3,675,200 sh (-42.12%)
Richard Snow 324,507 sh (-45.66%)
Paul Tudor Jones 10,000 sh (-94.76%)
» More
Q2 2014

WLP Guru Trades in Q2 2014

John Hussman 200,000 sh (New)
Yacktman Fund 1,406,800 sh (unchged)
Steven Romick 2,025,000 sh (unchged)
Vanguard Health Care Fund 3,675,200 sh (unchged)
Yacktman Focused Fund 1,400,000 sh (-12.5%)
» More
» Details

Insider Trades

Latest Guru Trades with WLP

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
John Hussman 2014-06-30 New Buy1.7%$92 - $108.82 $ 111.058%200000
Yacktman Focused Fund 2014-06-30 Reduce -12.5%0.21%$92 - $108.82 $ 109.817%1400000
John Hussman 2014-03-31 Sold Out 0.99%$84.25 - $100.97 $ 109.8122%0
Vanguard Health Care Fund 2014-03-31 Reduce -42.12%0.76%$84.25 - $100.97 $ 109.8122%3675200
James Barrow 2014-03-31 Reduce -24.36%0.56%$84.25 - $100.97 $ 109.8122%13212766
George Soros 2014-03-31 New Buy0.11%$84.25 - $100.97 $ 109.8122%110000
Tom Gayner 2014-03-31 Add 26.42%0.09%$84.25 - $100.97 $ 109.8122%134000
Ray Dalio 2014-03-31 New Buy0.01%$84.25 - $100.97 $ 109.8122%16026
Joel Greenblatt 2014-03-31 Add 235.3%0.01%$84.25 - $100.97 $ 109.8122%9127
Mario Gabelli 2014-03-31 New Buy$84.25 - $100.97 $ 109.8122%8000
Vanguard Health Care Fund 2013-12-31 Reduce -11.66%0.23%$83.6 - $93.92 $ 109.8124%6349200
Tom Gayner 2013-12-31 Add 35.9%0.08%$83.6 - $93.92 $ 109.8124%106000
Ray Dalio 2013-12-31 Sold Out 0.04%$83.6 - $93.92 $ 109.8124%0
David Dreman 2013-12-31 New Buy0.02%$83.6 - $93.92 $ 109.8124%2297
John Hussman 2013-09-30 New Buy0.69%$81.09 - $89.26 $ 109.8128%150000
Jean-Marie Eveillard 2013-09-30 Reduce -16.29%0.26%$81.09 - $89.26 $ 109.8128%5250235
Vanguard Health Care Fund 2013-09-30 Reduce -6.68%0.15%$81.09 - $89.26 $ 109.8128%7187500
Ray Dalio 2013-09-30 Add 63.39%0.02%$81.09 - $89.26 $ 109.8128%59026
David Dreman 2013-09-30 Sold Out 0.01%$81.09 - $89.26 $ 109.8128%0
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about WellPoint Inc

The Skinny on Health Care Stocks - Second Quarter Trades
A number of stocks in the health care sector are up over 12 months, and according to GuruFocus research, the billionaires are trading. The GuruFocus Buffett-Munger Screener highlights these medical and health care companies, and others, with high predictability and EBITDA growth rates. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 14.70
WLP's P/E(ttm) is ranked higher than
81% of the 36 Companies
in the Global Health Care Plans industry.

( Industry Median: 18.10 vs. WLP: 14.70 )
WLP' s 10-Year P/E(ttm) Range
Min: 4.25   Max: 23.5
Current: 14.7

4.25
23.5
P/B 1.20
WLP's P/B is ranked higher than
83% of the 36 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.06 vs. WLP: 1.20 )
WLP' s 10-Year P/B Range
Min: 0.71   Max: 2.27
Current: 1.2

0.71
2.27
P/S 0.50
WLP's P/S is ranked higher than
69% of the 36 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.51 vs. WLP: 0.50 )
WLP' s 10-Year P/S Range
Min: 0.26   Max: 1.11
Current: 0.5

0.26
1.11
PFCF 11.50
WLP's PFCF is ranked higher than
78% of the 36 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.97 vs. WLP: 11.50 )
WLP' s 10-Year PFCF Range
Min: 5.82   Max: 50.97
Current: 11.5

5.82
50.97
EV-to-EBIT 11.72
WLP's EV-to-EBIT is ranked higher than
69% of the 36 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.15 vs. WLP: 11.72 )
WLP' s 10-Year EV-to-EBIT Range
Min: 1.6   Max: 19.5
Current: 11.72

1.6
19.5
PEG 6.60
WLP's PEG is ranked higher than
72% of the 36 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.73 vs. WLP: 6.60 )
WLP' s 10-Year PEG Range
Min: 0.21   Max: 4.97
Current: 6.6

0.21
4.97
Shiller P/E 13.60
WLP's Shiller P/E is ranked higher than
97% of the 36 Companies
in the Global Health Care Plans industry.

( Industry Median: 37.84 vs. WLP: 13.60 )
WLP' s 10-Year Shiller P/E Range
Min: 6.76   Max: 22.82
Current: 13.6

6.76
22.82

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.50
WLP's Dividend Yield is ranked higher than
56% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.41 vs. WLP: 1.50 )
WLP' s 10-Year Dividend Yield Range
Min: 0.31   Max: 2.02
Current: 1.5

0.31
2.02
Dividend Payout 0.17
WLP's Dividend Payout is ranked higher than
89% of the 36 Companies
in the Global Health Care Plans industry.

( Industry Median: 9999.00 vs. WLP: 0.17 )
WLP' s 10-Year Dividend Payout Range
Min: 0.1   Max: 0.76
Current: 0.17

0.1
0.76
Yield on cost (5-Year) 1.50
WLP's Yield on cost (5-Year) is ranked lower than
63% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.04 vs. WLP: 1.50 )
WLP' s 10-Year Yield on cost (5-Year) Range
Min: 0.31   Max: 2.02
Current: 1.5

0.31
2.02
Share Buyback Rate 9.90
WLP's Share Buyback Rate is ranked higher than
96% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: -0.30 vs. WLP: 9.90 )
WLP' s 10-Year Share Buyback Rate Range
Min: 0   Max: -37
Current: 9.9

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 0.57
WLP's Price/DCF (Projected) is ranked higher than
94% of the 36 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.22 vs. WLP: 0.57 )
WLP' s 10-Year Price/DCF (Projected) Range
Min: 0.32   Max: 1.23
Current: 0.57

0.32
1.23
Price/Median PS Value 0.98
WLP's Price/Median PS Value is ranked higher than
75% of the 36 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.14 vs. WLP: 0.98 )
WLP' s 10-Year Price/Median PS Value Range
Min: 0.69   Max: 2.41
Current: 0.98

0.69
2.41
Earnings Yield (Greenblatt) 8.50
WLP's Earnings Yield (Greenblatt) is ranked higher than
64% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.40 vs. WLP: 8.50 )
WLP' s 10-Year Earnings Yield (Greenblatt) Range
Min: 5.1   Max: 63.3
Current: 8.5

5.1
63.3
Forward Rate of Return (Yacktman) 7.36
WLP's Forward Rate of Return (Yacktman) is ranked higher than
61% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.66 vs. WLP: 7.36 )
WLP' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 8   Max: 37.4
Current: 7.36

8
37.4

Business Description

Industry: Health Care Plans » Health Care Plans
Compare:UNH, ESRX, HUM, AET, CI » details
Traded in other countries:AE1.Germany
WellPoint Inc is an Indiana corporation incorporated on July 17, 2001. WellPoint is a health benefits company in terms of commercial membership in the United States, 34.3 million medical members. The Company offers a spectrum of network-based managed care plans to the large and small employer, individual, Medicaid and senior markets. Its managed care plans include: preferred provider organizations, or PPOs; health maintenance organizations, or HMOs; point-of-service plans, or POS plans; traditional indemnity plans and other hybrid plans, including consumer-driven health plans, or CDHPs; and hospital only and limited benefit products. In addition, The Company provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. It also provides an array of specialty products and services including life and disability insurance benefits, dental, vision, behavioral health benefit services, radiology benefit management, analytics-driven personal health care guidance and long-term care insurance. Finally, the Company provides services to the Federal Government in connection with the Federal Employee Program, or FEP, and various Medicare programs. The Company is licensed to conduct insurance operations in all 50 states through its subsidiaries. It is an independent licensee of the Blue Cross and Blue Shield Association, an association of independent health benefit plans. The Company manages its operations through three reportable segments: Commercial; Consumer; and Other. Commercial and Consumer segments both offer a mix of managed care products, including PPOs, HMOs, traditional indemnity benefits and POS plans, as well as a variety of hybrid benefit plans, including CDHPs, hospital only and limited benefit products. Commercial segment includes Local Group (including UniCare), National Accounts and certain other ancillary business operations (dental, vision, life and disability and workers' compensation). Business units in the Commercial segment offer fully-insured products and provide an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. Consumer segment includes Senior, State-Sponsored and Individual business. Senior business includes services such as Medicare Advantage (including private fee-for-service plans and special needs plans), Medicare Part D, and Medicare Supplement, while State-Sponsored business includes its managed care alternatives for Medicaid and State Children's Health Insurance Plan programs. Individual business includes individual customers under age 65 and their covered dependents. Other segment includ
» More Articles for WLP

Headlines

Articles On GuruFocus.com
Health Insurance Companies in Your Portfolio Jun 24 2014 
Maintain a Healthy Portfolio with Aetna Mar 24 2014 
Weekly CFO Sells Highlight: FleetCor Technologies Inc., Facebook Inc., Perrigo Company, WellPoint In Dec 15 2013 
The Skinny on Health Care Stocks - Second Quarter Trades Aug 07 2013 
Low P/E Stocks Guru Investors Are Buying Jul 26 2013 
Enough Apple Pie, Alan Fournier Unloads Major American Companies May 22 2013 
comment on WLP May 06 2013 
WellPoint (WLP) - A Comprehensive Value Analysis May 04 2013 
Simon Properties Reports Insider Trades Mar 13 2013 
comment on WLP Jan 27 2013 


More From Other Websites
DaVita Healthcare Beats on Q2 Earnings, Revises Guidance Aug 01 2014
Obamacare Becomes a Long-Term Tailwind for Creating Value for Senior Housing REITs: A Wall Street... Aug 01 2014
US STOCKS-S&P 500 nearly flat as investors digest Fed statement Jul 30 2014
US STOCKS-S&P 500 nearly flat as investors digest Fed statement Jul 30 2014
US STOCKS-S&P 500 turns higher after Fed statement Jul 30 2014
US STOCKS-S&P 500 turns higher after Fed statement Jul 30 2014
[video] Humana and WellPoint Slide After Reporting Lower Quarterly Profit Jul 30 2014
WellPoint, Humana Q2 Profit Down, Membership Up Jul 30 2014
[$$] WellPoint Lifts View Despite Profit Drop Jul 30 2014
Why WellPoint (WLP) Stock Is Lower Today Jul 30 2014
WellPoint (WLP) Q2 Earnings Beat, Down Y/Y on High Expenses Jul 30 2014
WellPoint 2Q tops Wall Street expectations Jul 30 2014
WellPoint 2Q tops Wall Street expectations Jul 30 2014
Water-Logged And Getting Wetter: WellPoint (WLP) Jul 30 2014
Wellpoint, Humana Obamacare Enrollment On The Rise Jul 30 2014
WellPoint says exchange business costs are as planned Jul 30 2014
WellPoint, Inc. Earnings Call scheduled for 8:30 am ET today Jul 30 2014
[video] Obamacare not affordable for many: Aetna CEO Jul 30 2014
WellPoint medical cost ratio drives 2nd-quarter profit beat Jul 30 2014
WellPoint Reports Second Quarter 2014 Results Jul 30 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide